➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Johnson and Johnson
McKinsey
Boehringer Ingelheim
AstraZeneca

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Talaporfin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Talaporfin?

Talaporfin is an investigational drug.

There have been 12 clinical trials for Talaporfin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.

The most common disease conditions in clinical trials are Liver Neoplasms, Neoplasms, and Hyperplasia. The leading clinical trial sponsors are Light Sciences Oncology, Light Sciences LLC, and Children's Hospital of Philadelphia.

Recent Clinical Trials for Talaporfin
TitleSponsorPhase
A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaMundipharma Research LimitedPhase 2
A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaLight Sciences OncologyPhase 2
Novel Treatment for Port Wine Stain BirthmarksBeckman Laser Institute University of California IrvinePhase 1

See all Talaporfin clinical trials

Clinical Trial Summary for Talaporfin

Top disease conditions for Talaporfin
Top clinical trial sponsors for Talaporfin

See all Talaporfin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Johnson and Johnson
McKinsey
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.